Back to search
FDAFDA · Food and drugs·Recall number D-0665-2022

Lorazepam 1 mg/mL Infusion Solution in 250 mL bags, Rx only, Family Pharmacy of Statesville, Inc.

Published March 23, 2022 · Recall initiated: August 6, 2020

Summary

FDA records drug Class II recall D-0665-2022, published March 23, 2022 and initiated August 6, 2020. Recalling firm: Family Pharmacy of Statesville; Status: Terminated; Reported quantity: 1 bag; Lot: Lot #: 07312020@6 BUD: 8/7/2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Family Pharmacy of Statesville
Distributor
NC only
Lot
Lot #: 07312020@6 BUD: 8/7/2020
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lorazepam 1 mg/mL Infusion Solution in 250 mL bags, Rx only, Family Pharmacy of Statesville, Inc. recalled?

Yes. FDA published recall D-0665-2022 on March 23, 2022. Reported hazard: Lack of Assurance of Sterility

What should I do if I have this product?

Voluntary: Firm initiated · Telephone